Has Debra Nowak received payments from drug or device companies?

Yes. Drug and device makers reported $214 in general payments to Debra Nowak across 10 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Debra Nowak did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Debra Nowak come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Debra Nowak

Family · Fort Leonard Wood, MONPI 1255630216

Payments from drug & device makers

$214in general payments, 2019–2025

Across 10 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$53
Myriad Genetic Laboratories, Inc.$37
Heron Therapeutics, Inc.$32
KCI USA, Inc.$25
KARL Storz Endoscopy-america$18
Pacira Pharmaceuticals Incorporated$17
plus $32 from 2 others

What the payments were for

Food & beverage$214100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	2	$53
Myriad Genetic Laboratories, Inc.	2	$37
Heron Therapeutics, Inc.	1	$32
KCI USA, Inc.	1	$25
KARL Storz Endoscopy-america	1	$18
Pacira Pharmaceuticals Incorporated	1	$17
Innocoll Pharmaceuticals Limited	1	$16
Bard Peripheral Vascular, Inc.	1	$15

How this compares

$214 in reported general payments places this provider in the 35th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Medicare billing

Part B allowed, 2024

$24,404

Medicare patients

108

Services billed

212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	63	$573
Methylprednisolone	48	$379
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	24	$241
Baclofen	23	$191
Gabapentin	15	$154
Methocarbamol	16	$151
Tramadol Hcl	17	$38

Paid to pharmacies, not to this prescriber.

Other family in Fort Leonard Wood

Connie SpencerSaint Joseph$320K
Shayla SandersKansas City$306K
Tamera WolfLees Summit$215K
Tiffany ArnoldFestus$177K
Tiffany NelsonSedalia$164K
Chelsey BeckerSaint Peters$104K
Carey PattonDes Peres$94K
Marcy MarkesColumbia$92K
Laura HedigerSpringfield$71K
Rebecca SeabaughSaint Louis$68K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →